💉 Weight Loss Drug Dose Titration Schedule Simulator

Week Zero — Why Weight-Loss Drugs Start Low

Lowest dose tier limits nausea while the gut adapts.

• 2.5 mg: Starting dose (lowest available tier)
• 4 wks: Duration (before first step-up)
• ~8%: GI risk (mild nausea, low incidence)
• ~0%: Weight loss (adaptation phase)

Starting low reduces early GI intolerance

Short placeholder: low starting dose limits nausea onset. Gradual receptor adaptation lowers dropout risk early on.

First Step-Up — Advancing to the Next Tier

Dose doubles roughly every four weeks if tolerated.

• 5.0 mg: New dose (second tier)
• 4 wks: Step interval (standard schedule)
• ~14%: GI risk (mild uptick post-step)
• ~2%: Weight loss (early trend emerging)

Each step slightly raises transient GI risk

Short placeholder: side effects spike briefly after each increase. Risk fades as the body re-adapts before next step.

Continued Titration Toward the Effective Range

Successive steps climb the dose ladder every few weeks.

• 7.5–10 mg: Dose range (tiers 3–4)
• 8–12: Cumulative weeks (since start)
• ~17%: GI risk (peaks near step points)
• ~6%: Weight loss (accelerating progress)

Repeated steps compound tolerability and efficacy

Short placeholder: cumulative titration builds tolerance over time. Weight loss accelerates as effective dose approaches.

Maintenance Dose — Weeks 16 to 20

Full target dose reached; side effects largely plateau.

• 12.5 mg: Maintenance dose (top tier)
• Wk 16–20: Reached by (depending on schedule)
• ~12%: GI risk (stabilized, declining)
• ~11%: Weight loss (steady ongoing trend)

Plateauing side effects at steady-state dose

Short placeholder: body reaches steady state at maintenance. GI symptoms taper while weight loss keeps progressing.

Slow vs Fast Titration — The Tolerability Trade-off

Slow titration trims side-effect spikes at a time cost.

• ~9%: Slow-titration GI peak (6-week steps)
• ~38%: Fast-titration GI peak (2-week steps)
• 20–30 wks: Time to maintenance (slow vs fast range)
• ~15%: Final weight loss (similar across schedules)

Slower ramps trade time for tolerability

Short placeholder: slow schedules cut side effects substantially. Fast schedules reach maintenance sooner but spike GI events.

Short placeholder: pick titration speed based on patient tolerance.